Agilent Technologies is a diagnostic & research company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker A on the NYSE exchange.
Agilent Technologies stock last closed at $169.33, down 1.14% from the previous day, and has increased 19.57% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.04 percentage points. Agilent Technologies stock is currently +56.28% from its 52-week low of $108.35, and -4.36% from its 52-week high of $177.05.
There are currently 281.93M shares of A outstanding. The market cap of A is $47.74B. In the last 24 hours, 1.87M A shares were traded.
You need a brokerage account in order to access the NYSE market and buy A shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you'll need to fill out some personal details so you can invest in A today.
Now that you have created your account on the best stock buying app, you need to deposit funds:
Check out the walkthrough below for more details depositing funds into your brokerage account.
Once you have identified the best place to buy Agilent Technologies stock, it's critical to evaluate their stock before you invest, so you actually understand the risk and upside.
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can see all of the due diligence checks on A's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge A's true value.
Using relative valuations ratios:
You can access more valuation analysis on A's stock here.
Out of 18 Wall Street analysts who give recommendations on A, the consensus analyst rating on Agilent Technologies is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Casey Woodring, a top 12% analyst from JP Morgan maintains A with a strong buy rating and raises their A price target from $180.00 to $190.00, on Aug 27, 2026.
Dan Brennan, a top 3% analyst from TD Cowen maintains A with a strong buy rating and raises their A price target from $155.00 to $180.00, on Aug 27, 2026.
TD Cowen's Dan Brennan raised their price target on Agilent Technologies (NYSE: A) by 16.1% from $155 to $180 on 2026/08/27. The analyst maintained their Strong Buy rating on the stock.
Agilent Technologies reported its Q3 2026 earnings.
Raising their price target, Brennan called the quarter's results robust, highlighted improved revenue, margin, and the EPS beat.
The analyst called execution the reason for the success, pointing to new innovation driving instruments.
For Q3 2026, Agilent Technologies reported:
Management guided:
For Q4 2026:
For FY 2026:
CEO CEO Padraig McDonnell commented: “Agilent’s exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System.
“We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches.
“All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets.”
Eve Burstein, a top 26% analyst from Bernstein maintains A with a buy rating and raises their A price target from $155.00 to $180.00, on Aug 27, 2026.
Dan Leonard, a top 7% analyst from RBC Capital maintains A with a buy rating and raises their A price target from $155.00 to $185.00, on Aug 27, 2026.
Vijay Kumar, a top 16% analyst from Evercore ISI Group maintains A with a buy rating and raises their A price target from $148.00 to $172.00, on Aug 27, 2026.
You can dig deeper into what analysts are saying on the Agilent Technologies stock forecast page.
Last year, A earnings were $1.44B. During the past five year, A's earnings have gone up by 9.5% per year. This was faster than the Diagnostics & Research industry average of -0.22%.
Last year, A revenue was $7.37B. During the last 5 year, A's revenue has increased by 3.72% per year. This was slower than the Diagnostics & Research industry average of 7.48%.
Dig into A's earnings and revenue performance here.
Over the past year, executives and large shareholders at A have bought more shares than they have sold.
Glenn S. Boehnlein, Director of A, was the latest A insider to buy. They bought $119,976.45 worth of A shares on Sep 8, 2026.
Get more info about who owns A shares here.
Agilent Technologies pays a dividend of 0.6%, compared to the Diagnostics & Research industry's average dividend yield of 1.31%. If you owned $1,000 worth of A stock, you would have received $6.02 last year.
Agilent Technologies dividend payments have consistently grown over the past decade and have remained stable.
Get more analysis about Agilent Technologies dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main options:
Press the Open Trade button and eToro will execute your order.
If you require additional info about buying stocks on eToro, watch the how to video below:
Now that you own some A shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track your A stock.
To reiterate, here are the 6 steps to buy stock in Agilent Technologies:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Agilent Technologies, create a watchlist on WallStreetZen today.